Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis.

Ghulam Murtaza,Mohit K Turagam,Jalaj Garg, Urooge Boda,Krishna Akella,Poonam Velagapudi,Andrea Natale,Rakesh Gopinathannair,Dhanunjaya Lakkireddy

Indian pacing and electrophysiology journal（2021）

引用 2|浏览3

暂无评分

摘要

Apixaban had an overall favorable risk-benefit profile, with significant reductions in ischemic stroke, major bleeding, and intracranial bleeding compared to Warfarin in ESRD patients on hemodialysis with non-valvular AF and/or venous thromboembolism.

查看译文

关键词

Apixaban,Dialysis,End-stage renal disease,Meta-analysis,Warfarin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要